Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
The Manual for Decent European Urban communities in 2024 - 2Extreme Manual for Purchasing Your Next Truck
- 3Spanish police and soldiers track boars, reinforce farm security amid swine fever outbreak
- 4EU top diplomat Kallas arrives in Kiev to commemorate Bucha massacre
- 5Merz says army could be involved in mine-clearing from Hormuz
- Denny's is shutting down restaurants around the country. What's behind the closures?
- Investigating the Advantages of a Bank account: A Complete Aide
- German Easter peace marches draw tens of thousands
- Oprah Winfrey's Favorite Wellness Destination Is A Luxurious Italian Retreat
- Investigating the World's Chief Authentic Urban communities to Visit
- How to identify animal tracks, burrows and other signs of wildlife in your neighborhood
- Spanish bishops and government sign deal for compensation of church sexual abuse victims
- Rights groups condemn Israel Police decision to ban Sudan Genocide protests nationwide
- Top notch Feasting: A Manual for Worldwide Acclaimed Eateries
